Deans' stroke musings: Ginkgo Biloba Compound Shows Promise in Cognitive Recovery After Stroke

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Sunday, February 4, 2024

Ginkgo Biloba Compound Shows Promise in Cognitive Recovery After Stroke

There's nothing you can do with this on your own since this is an injection. You'll just have to wait 50 years before it becomes a protocol. Hope you can hold off having a stroke for that long.

Ginkgo Biloba Compound Shows Promise in Cognitive Recovery After Stroke

Summary: A preliminary study reveals that intravenous injections of ginkgo biloba components could significantly improve early cognitive recovery in ischemic stroke patients.

Conducted across multiple centers in China, the research tested the effects of ginkgo diterpene lactone meglumine (GDLM) on 3,163 stroke survivors, showing notable improvements in cognitive scores compared to a placebo group.

This study suggests that GDLM’s neuroprotective properties, including antioxidation and anti-inflammation, may offer a new avenue for enhancing post-stroke cognitive function. However, these findings, funded by the drug’s manufacturer, highlight the need for further research to confirm efficacy and safety before considering clinical use.

Key Facts:

Stroke survivors treated with GDLM showed significant cognitive improvement over those receiving a placebo, suggesting potential benefits for post-stroke recovery.
GDLM injections are based on the active components of ginkgo biloba, an herb used traditionally in China and recognized for its antioxidant properties.
The study’s promising results call for more extensive trials to verify the safety and effectiveness of GDLM in stroke recovery, underlining the importance of cautious integration of complementary medicines into cardiovascular care.

Source: American Heart Association

People with ischemic (clot-caused) stroke had better early recovery of cognitive function if treated with intravenous injections of a combination of biologically active components of ginkgo biloba during the first two weeks after the stroke, according to a preliminary study to be presented at the American Stroke Association’s International Stroke Conference 2024.

The meeting will be held in Phoenix, Feb. 7-9, and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.